insights_auto
Why is CMXHF up 2,22%?
Dive Deeperchevron_right
CMXHF:OTCMKTS
CSL Ltd
123,79 $
arrow_upward
+2,22%(+2,69) 1D
15 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CMXHF...
Open
129,22 $
High
129,22 $
Low
123,79 $
Mkt. cap
92,23 մլրդ
Avg. vol.
167,00
Volume
564,00
52-wk high
148,36 $
52-wk low
63,84 $
Beta
0,56
Shares outstanding
479,88 մլն
No. of employees
29 հզր
Open
129,22 $
High
129,22 $
Low
123,79 $
Mkt. cap
92,23 մլրդ
Avg. vol.
167,00
Volume
564,00
52-wk high
148,36 $
52-wk low
63,84 $
Beta
0,56
Shares outstanding
479,88 մլն
No. of employees
29 հզր
News stories
From web sources and news partners
TheBull.com.au
·
2 օր առաջ
CSL Shares Double Off Lows: How Do They Stack Up Against TLX, SIG?
ad-hoc-news.de
·
2 օր առաջ
CSL agrees Alentis drug deal as CSL stock has AUD 89.7 billion value
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29 հզր
Founded1916
HeadquartersՄելբուրն, Վիկտորիա, Ավստրալիա
Sector-
Websitecsl.com